Blonder Tongue Laboratories, Inc. (BDR) Stock Overview
Explore Blonder Tongue Laboratories, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Blonder Tongue Laboratories, Inc. (BDR)
Key Financials
Key Financials
Market Cap
0
P/E Ratio
-1.39
EPS (TTM)
$-0.05
ROE
0.10%
BDR Stock Analysis & Investment Overview (AMEX)
Our AI-powered analysis of Blonder Tongue Laboratories, Inc. (AMEX: BDR) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Blonder Tongue Laboratories, Inc.'s AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of BDR on the AMEX shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the AMEX listing.
Key metrics behind Blonder Tongue Laboratories, Inc.'s AMEX-traded stock include a P/E ratio of -1.39 and a market capitalization of 0. Combined with our AI analysis, these give both institutional and retail investors a clear view of BDR on the AMEX.